College of Medicine
Bryant Lab
Led by Andrew J Bryant · Medicine
What we study
The Bryant Lab studies how immune cells and circadian rhythms contribute to pulmonary hypertension, using small animal models and clinical research. They explore how these cells are regulated by STING signaling and the brain.
What working here is like
- Wet lab
- Clinical
- Mice
- Human participants
- Papers
- 5
What we're looking for
“The Bryant Lab is inclusive and welcomes inquiries from postdoctoral fellows, and graduate and undergraduate students interested in translational research in pulmonary vascular disease.”
Recent papers, explained
- Pulmonary Arterial Hypertension in Octogenarians: The Pulmonary Hypertension Association Registry
2026 · Pulmonary Circulation
Compares clinical features and outcomes of octogenarians with PAH to younger patients.
- Prediction of intubation risk in patients with alcohol withdrawal using explainable machine learning
2026 · Scientific Reports
Uses machine learning to predict intubation risk in alcohol withdrawal patients.
Show 3 more papersShow fewer
- Catch a TIGAR by the Tail: YTHDC1 Links Epitranscriptomic Regulation to Macrophage-Driven Pulmonary Hypertension
2026 · American Journal of Respiratory and Critical Care Medicine
Links YTHDC1 to macrophage-driven pulmonary hypertension through epitranscriptomic regulation.
- Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension
2025 · JCI Insight
- Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension
2025 · Annals of the American Thoracic Society
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Andrew J Bryant hasn't set up this page yet. You can also look them up in the UF directory (search “Andrew J Bryant”).